Norfolk, VA — October 29, 2025 — Synap Biotech Inc™., a biotechnology company pioneering intranasal nanobody based therapies for neurological recovery, is pleased to announce the appointment of Dr. Pallavi Tawde as Chief Scientific Officer and Co-Founder.

Norfolk, VA — December 2, 2025 — Synap Biotech, Inc.™, a biotechnology company pioneering intranasal Nanobody®-based therapies to unlock brain repair, is pleased to announce that Prof. Serge Muyldermans, the original pioneer of Nanobody® technology and co-founder of Ablynx N.V., has joined the company’s Scientific Advisory Board (SAB).